Literature DB >> 8037158

Use of lyophilized calibration plasmas and control blood for international normalized ratio calculation in external quality assessment of the prothrombin time.

A M van den Besselaar1.   

Abstract

In the Netherlands, most anticoagulant clinics (thrombosis centers) use the reagent Thrombotest with citrated venous blood for laboratory control of oral anticoagulant therapy. In a national external quality assessment scheme, artificial control blood samples were mailed to 160 participants. Each participant returned prothrombin times and international normalized ratio (INR) values for these blood samples. The author investigated whether local calibration with lyophilized plasmas could reduce the interlaboratory variation of the INR. Five lyophilized plasmas were mailed along with the control blood samples. Using a local calibration line determined with the lyophilized plasmas, the interlaboratory variation of INRs determined routinely could be reduced slightly from 5.8% to 7% coefficient of variation (CV) to 5.3% to 6.5% CV. In contrast, when a local calibration line was determined with four similar control blood samples, the interlaboratory variation of the INR was reduced substantially to 2.5% CV.

Entities:  

Mesh:

Year:  1994        PMID: 8037158     DOI: 10.1093/ajcp/102.1.123

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Multicentre evaluation of the Thrombotest International Sensitivity Index used with a steel ball coagulometer.

Authors:  A M van den Besselaar; R H Peters
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

2.  Field study of lyophilised plasmas for local prothrombin time calibration in The Netherlands.

Authors:  A M van den Besselaar
Journal:  J Clin Pathol       Date:  1997-05       Impact factor: 3.411

3.  The importance of "like to like" ISI calibrations with freeze dried plasmas. European Concerted Action on Anticoagulation.

Authors:  L Poller; A M van den Besselaar; J Jespersen; A Tripodi; D Houghton
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.